Aria Health Physicians Reach Procedural Milestone
Physicians at Aria Health have recently completed their 50th robotic catheter ablation procedure with the Stereotaxis (NASDAQ: STXS) Epoch Platform for complex cardiac conditions. Epoch is a state-of-the-art computer controlled robotic navigation system that allows physicians to safely navigate in a patient's heart to ablate diseased tissue causing cardiac arrhythmias or irregular heartbeats.
The advanced computer-controlled technology from Stereotaxis allows Aria's electrophysiologists Bradley Bacik, DO, Roger A. Marinchak MD, and Scott Spielman, MD, to treat common and complex cardiac arrhythmias with a great degree of safety, precision, and efficiency. The physician uses sophisticated software to draw a highly detailed 3D map of the diseased cardiac tissue, and drive powerful magnets positioned near the patient. Following the map, the magnets steer a soft catheter gently through the patient's cardiac anatomy by guiding the catheter's magnetic tip. As a result, the patient is exposed to up to 60% less damaging X-ray radiation. There's also ten times less chance of major complications, such as perforation of the heart.
"This is one of many cutting edge technologies available at the Heart Center at Aria Health-Torresdale," said Dr. Bacik. "We've been able to make tremendous advances, achieving unparalleled levels of success and safety for our patients."
"Utilizing this technology highlights another example of how our Heart Center is committed to constantly seeking ways to improve service, safety, and quality care to our patients and community," said Dr. Marinchak.
"Another important benefit of remote magnetic navigation is the significant reduction of radiation exposure to our patients, and to our staff," added Dr. Spielman.
More than five million people in the United States currently suffer from abnormal heart rhythms, known as arrhythmias or irregular heartbeats. Those who suffer from these abnormal heart rhythms are five to seven times more likely to have a stroke or experience more permanent damage to the heart. Atrial fibrillation is one of the most common arrhythmias, affecting about 2.6 million people in the United States. People with this condition are five to seven times more likely to have a stroke, and also may suffer from permanent damage to the heart, such as congestive heart failure and dilated heart chambers. A growing number of complex cardiac interventional procedures are driving the need for new technology that enables physicians to confidently treat areas of the heart previously unreachable or potentially unsafe with manual techniques.